skip to content
Textbook of psychiatric epidemiology Preview this item
ClosePreview this item

Textbook of psychiatric epidemiology

Author: Ming T Tsuang; Mauricio Tohen; Peter B Jones
Publisher: Chichester, West Sussex ; Hoboken, NJ : Wiley-Blackwell, 2011.
Edition/Format:   Print book : English : 3rd edView all editions and formats
The new edition of this textbook continues to provide the most comprehensive overview of the concepts, methods, and research advances in the field; particularly the application of molecular genomics and of neuroimaging. It has been revised and enhanced to capitalize on the strengths of the first and second editions while keeping it up-to-date with the field of psychiatry and epidemiology. This comprehensive  Read more...

(not yet rated) 0 with reviews - Be the first.

More like this


Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...


Document Type: Book
All Authors / Contributors: Ming T Tsuang; Mauricio Tohen; Peter B Jones
ISBN: 9780470694671 047069467X 9780470976722 0470976721 9780470976739 047097673X 9780470977408 047097740X
OCLC Number: 678397561
Notes: Rev. ed. of: Textbook in psychiatric epidemiology / edited by Ming T. Tsuang, Mauricio Tohen. 2nd ed. c2002.
Description: xiv, 646 p. : ill. ; 26 cm.
Contents: List of Contributors. <p>1 Introduction to epidemiologic research methods (GlynLewis). <p>1.1 What is epidemiology? <p>1.2 Causation in medicine. <p>1.3 Causal inference. <p>1.4 The future for psychiatric epidemiology. <p>2 Analysis of categorical data: The odds ratio as a measureof association and beyond (Garrett M. Fitzmaurice andCaitlin Ravichandran). <p>2.1 Introduction. <p>2.2 Inference for a single proportion. <p>2.3 Analysis of 2 x 2 contingency tables. <p>2.4 Analysis of sets of 2 x 2 contingency tables. <p>2.5 Logistic regression. <p>2.6 Advanced topics. <p>2.7 Concluding remarks. <p>2.8 Further reading. <p>3 Genetic epidemiology (Stephen V. Faraone, Stephen J.Glatt and Ming T. Tsuang). <p>3.1 Introduction. <p>3.2 The chain of psychiatric genetic research. <p>3.3 Psychiatric genetics and psychiatric epidemiology. <p>4 Examining gene environment interplay in psychiatricdisorders (Judith Allardyce and Jim van Os). <p>4.1 Introduction. <p>4.2 The process of genetic epidemiology. <p>4.3 Gene environment interplay takes different forms. <p>4.4 Gene environment correlation. <p>4.5 Gene environment interaction. <p>4.6 Measurement of genotype, environmental exposure andpathological phenotype. <p>4.7 Models of GxE. <p>4.8 Which scale should we use to measure GxE? <p>4.9 Study designs for the detection of GxE. <p>4.10 Threats to the validity of epidemiological GxE studies. <p>4.11 Epigenetic mechanisms. <p>5 Reliability (Patrick E. Shrout). <p>5.1 Introduction. <p>5.2 The reliability coefficient. <p>5.3 Designs for estimating reliability. <p>5.4 Statistical remedies for low reliability. <p>5.5 Reliability theory and binary judgements. <p>5.6 Reliability statistics: General. <p>5.7 Other reliability statistics. <p>5.8 Summary and conclusions. <p>6 Moderators and mediators: Towards the genetic andenvironmental bases of psychiatric disorders (Helena ChmuraKraemer). <p>6.1 Introduction. <p>6.2 Current methodological barriers. <p>6.3 Moderation, mediation and other ways in which risk factors'work together'. <p>6.4 Extensions. <p>6.5 Beyond moderators and mediators. <p>7 Validity: Definitions and applications to psychiatricresearch (Jill M. Goldstein, Sara Cherkerzian and John C.Simpson). <p>7.1 Introduction. <p>7.2 Validity of a construct. <p>7.3 Validity of the relationships between variables. <p>7.4 Summary. <p>8 Use of register data for psychiatric epidemiology in theNordic countries (Jouko Miettunen, Jaana Suvisaari, JariHaukka and Matti Isohanni). <p>8.1 Introduction. <p>8.2 Registers for use in psychiatric research. <p>8.3 Register research in Denmark. <p>8.4 Register research in Finland. <p>8.5 Register research in Norway. <p>8.6 Register research in Sweden. <p>8.7 Discussion. <p>9 An introduction to mental health services research(Anna Fernandez, Alejandra Pinto-Meza, Antoni Serrano-Blanco,Jordi Alonso and Josep Maria Haro). <p>9.1 Introduction. <p>9.2 What is mental health services research? <p>9.3 A framework for mental health services research. <p>9.4 Key concepts in mental health services research. <p>9.5 Examples of mental health services research studies. <p>9.6 Conclusion. <p>10 The pharmacoepidemiology of psychiatric medications(Philip S. Wang, Alan M. Brookhart, Christine Ulbricht andSebastian Schneeweiss). <p>10.1 Introduction. <p>10.2 Overview of psychopharmacoepidemiology. <p>10.3 Sources of data. <p>10.4 Examples of recent psychopharmacoepidemiologic studies. <p>10.5 Conclusions. <p>11 Peering into the future of psychiatric epidemiology(Michaeline Bresnahan, Ezra Susser, Dana March and BruceLink). <p>11.1 Introduction. <p>11.2 Levels of causation: A historical overview. <p>11.3 Levels of causation. <p>11.4 Causation over (life) time. <p>11.5 Examples. <p>11.6 Framing the future. <p>12 Studying the natural history of psychopathology(William W. Eaton). <p>12.1 Introduction. <p>12.2 Onset. <p>12.3 Course. <p>12.4 Outcome. <p>12.5 Methodological concepts for studying the natural history ofpsychopathology. <p>12.6 Conclusion. <p>13 Symptom scales and diagnostic schedules in adultpsychiatry (Jane M. Murphy). <p>13.1 Introduction. <p>13.2 North American instruments for epidemiologicalresearch. <p>13.3 North American instruments for psychiatric services andprimary care. <p>13.4 European instruments for psychiatric services and primarycare. <p>13.5 European instruments for epidemiological research. <p>13.6 Summary. <p>14 The National Comorbidity Survey (NCS) and itsextensions (Ronald C. Kessler). <p>14.1 Introduction. <p>14.2 The baseline NCS. <p>14.3 The NCS follow-up survey (NCS-2). <p>14.4 The NCS replication survey (NCS-R). <p>14.5 The NCS-R adolescent supplement (NCS-A). <p>14.6 The WHO WMH Surveys. <p>14.7 Overview. <p>15 Experimental epidemiology (John R. Geddes). <p>15.1 Introduction. <p>15.2 Limitations of non-randomised evidence. <p>15.3 RCTs: The translation of the experimental design into thereal world. <p>15.4 Importance and control of systematic error or bias. <p>15.5 Importance and control of random error and noise. <p>15.6 Reporting the results of clinical trials the CONSORTstatement. <p>15.7 Different clinical questions will prioritise control ofdifferent threats to validity and confidence. <p>15.8 The classification of RCTs. <p>15.9 Effectiveness trials in schizophrenia. <p>15.10 Department of Veterans Affairs co-operative study on thecost-effectiveness of Olanzapine (Rosenheck). <p>15.11 The clinical antipsychotic trials of interventioneffectiveness (CATIE) study. <p>15.12 Cost utility of the latest antipsychotic drugs inschizophrenia study (CUtLASS 1). <p>15.13 European first-episode schizophrenia trial (EUFEST). <p>15.14 The size and cost of experimental studies inpsychiatry. <p>15.15 Clinical trials in the future. <p>16 Epidemiology of Schizophrenia (William W. Eaton,Chuan-Yu Chen and Evelyn J. Bromet). <p>16.1 Introduction. <p>16.2 Methods. <p>16.3 The burden of schizophrenia. <p>16.4 Natural history. <p>16.5 Demographic correlates. <p>16.6 Social risk factors. <p>16.7 Biological risk factors. <p>16.8 Prevention. <p>16.9 Discussion. <p>17 Epidemiology of depressive disorders (Deborah S.Hasin, Miriam C. Fenton and Myrna M. Weissman). <p>17.1 Introduction. <p>17.2 Major depression. <p>17.3 Dysthymia. <p>17.4 Summary. <p>18 Epidemiology of anxiety disorders (Ewald Horwath,Felicia Gould and Myrna M. Weissman). <p>18.1 Introduction. <p>18.2 Anxiety disorders. <p>18.3 Panic disorder. <p>18.4 Agoraphobia. <p>18.5 Social phobia. <p>18.6 Generalised anxiety disorder. <p>18.7 Obsessive compulsive disorder. <p>18.8 Anxiety and affective disorders and mass disasters. <p>18.9 Future developments. <p>19 Epidemiology of bipolar disorder in adults andchildren (Kathleen R. Merikangas and MauricioTohen). <p>19.1 Introduction. <p>19.2 Epidemiology of bipolar disorder. <p>19.3 Patterns of comorbidity of bipolar disorder. <p>19.4 Risk Factors. <p>19.5 Future directions. <p>19.6 Summary. <p>20 Epidemiology of eating disorders (Tracey D. Wade,Anna Keski-Rahkonen and James I. Hudson). <p>20.1 Introduction. <p>20.2 Case definition. <p>20.3 Major prevalence studies. <p>20.4 Incidence studies. <p>20.5 Comorbidity. <p>20.6 Mortality from eating disorders. <p>20.7 Risk factors. <p>20.8 Future directions. <p>21 Epidemiology of alcohol use, abuse and dependence(Deborah A. Dawson, Ralph W. Hingson and Bridget F.Grant). <p>21.1 Introduction. <p>21.2 Population estimates of per capita consumption. <p>21.3 Survey-based estimates of the prevalence of drinking. <p>21.4 Alcohol-related mortality and morbidity. <p>21.5 Alcohol and injury. <p>21.6 Alcohol and chronic disease. <p>21.7 Diagnostic classification of alcohol use disorders. <p>21.8 Population estimates, prevalence, incidence and naturalcourse of alcohol use disorders. <p>21.9 Comorbidity of DSM-IV alcohol use disorders and otherpsychiatric disorders. <p>21.10 Summary. <p>22 Epidemiology of illicit drug use disorders (WilsonM. Compton, Marsha F. Lopez, Kevin P. Conway and Yonette F.Thomas). <p>22.1 Introduction. <p>22.2 Drug consumption. <p>22.3 Definitions. <p>22.4 Rates of DSM-IV abuse and dependence. <p>22.5 Global rates of drug use disorders. <p>22.6 Comorbidities with psychiatric conditions. <p>22.7 Genetic epidemiology. <p>22.8 Future opportunities. <p>22.9 Conclusions. <p>22.10 Disclaimer. <p>23 The epidemiology of personality disorders: Findings,methods and concepts (Michael J. Lyons, Beth A. Jerskey andMargo R. Genderson). <p>23.1 Introduction. <p>23.2 Substantive findings. <p>23.3 Course, prognosis and developmental issues. <p>23.4 Treated prevalence. <p>23.5 Prevalence of specific personality disorders. <p>23.6 Antisocial personality disorder. <p>23.7 Conceptual issues. <p>23.8 Models of personality disorder. <p>23.9 Methodological issues. <p>23.10 Future directions. <p>24 The epidemiology of depression and anxiety in children andadolescents (Kathleen Ries Merikangas and Erin F.Nakamura). <p>24.1 Introduction. <p>24.2 Magnitude of depression and anxiety in children andadolescents. <p>24.3 Correlates and risk factors. <p>24.4 Service patterns and impact. <p>24.5 Summary. <p>25 Epidemiology of attention deficit hyperactivitydisorder (Stephen V. Faraone). <p>25.1 Introduction. <p>25.2 Prevalence of ADHD. <p>25.3 Pharmacoeconomics of ADHD. <p>25.4 Comorbid psychiatric disorders. <p>25.5 Demographic risk factors. <p>25.6 Genetic risk factors. <p>25.7 Environmental risk factors for ADHD. <p>25.8 Summary and conclusions. <p>25.9 Future directions. <p>26 The epidemiology of autism (Gregory S.Liptak). <p>26.1 Introduction. <p>26.2 Background. <p>26.3 Definition and diagnosis. <p>26.4 Natural history. <p>26.5 Prevalence. <p>26.6 Risk factors. <p>26.7 Genetic factors. <p>26.8 Public health impact. <p>26.9 Associations and causal factors. <p>26.10 Future directions. <p>26.11 Summary. <p>27 Mental illness, women, mothers and their children(Kathryn M. Abel and Vera A. Morgan). <p>27.1 Introduction. <p>27.2 The epidemiology of mental illness in women of reproductiveage. <p>27.3 Fertility and fecundity in women with mental illness. <p>27.4 Maternal mental illness at the time of conception andduring pregnancy. <p>27.5 Gene environment interactions and offspringoutcomes. <p>27.6 Obstetric complications and risk of adult onset mentaldisorder in offspring. <p>27.7 Parental condition. <p>27.8 Motherhood and perinatal mental illness. <p>27.9 Designing studies examining the relationship betweenmaternal mental illness and outcomes for their children. <p>27.10 Conclusions. <p>28 Epidemiology of suicide and attemptedsuicide(Dianne Currier and Maria A. Oquendo). <p>28.1 Introduction. <p>28.2 Definitions. <p>28.3 Prevalence of suicide and attempted suicide. <p>28.4 Risk factors for suicide and attempted suicide. <p>28.5 Protective factors. <p>28.6 Conclusions. <p>29 Epidemiology and geriatric psychiatry (Celia F.Hybels and Dan G. Blazer). <p>29.1 Introduction. <p>29.2 Issues of case identification. <p>29.3 The distribution of cases. <p>29.4 Aetiological studies. <p>29.5 Outcome studies. <p>29.6 Historical trends in the epidemiology of psychiatricdisorders in late life. <p>29.7 Use of health care services. <p>30 Recent epidemiological studies of psychiatricdisorders in Japan (Masayoshi Kawai, Kenji J. Tsuchiya andNori Takei). <p>30.1 Introduction. <p>30.2 Schizophrenia. <p>30.3 Affective disorders. <p>30.4 Autism and autism spectrum disorder. <p>30.5 Summary. <p>31 Epidemiology of migration and serious mental illness: Theexample of migrants to Europe (Monica Charalambides, CraigMorgan and Robin M. Murray). <p>31.1 Introduction. <p>31.2 Defining the constructs. <p>31.3 High rates of psychosis in migrants: A genuine finding ormethodological artefact? <p>31.4 Possible explanations. <p>31.5 Biological considerations. <p>31.6 Cannabis use. <p>31.7 Adverse social experiences. <p>31.8 Mechanisms. <p>31.9 Implications. <p>32 Epidemiology of migration substance use disorder in LatinAmerican populations and migration to the United States(Mar a Elena Medina-Mora, Guilherme Borges, Tania Real andJorge Villatoro). <p>32.1 Introduction. <p>32.2 Definitions: What do we understand by migration? <p>32.3 Countries of origin: Social, political and other reasonsthat trigger migration. <p>32.4 Living conditions of migrants in the United States. <p>32.5 Alcohol and drug use in countries of origin and receivingcommunities. <p>32.6 Dependence and treatment rates. <p>32.7 The process of migrating. <p>32.8 Migration, substance use and access to services. <p>32.9 Returning migrants and families left behind. <p>32.10 Conclusions. <p>33 Early detection and intervention as approaches forpreventing schizophrenia (Ming T. Tsuang, William S. Stone,Margo Genderson and Michael Lyons). <p>33.1 Introduction. <p>33.2 Modelling genetic and phenotypic heterogeneity. <p>33.3 Defining a syndrome of liability using cognitive andclinical characteristics of relatives. <p>33.4 Gene-based vs. genome-based research. <p>33.5 Future directions. <p>33.6 Clinical implications. <p>Acknowledgements. <p>References. <p>Index.
Other Titles: Textbook in psychiatric epidemiology.
Responsibility: edited by Ming Tsuang, Mauricio Tohen, Peter B. Jones.


The new edition of this critically praised text continues to provide the most comprehensive overview of the concepts, methods, and research advances in the field, particularly the application of  Read more...


Editorial reviews

Publisher Synopsis

"The Textbook of Psychiatric Epidemiology is a timely,up-to-date, and comprehensive book covering all aspects of thescience of epidemiology as related to psychiatric disorders.Overall, this is a well Read more...

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...


Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data

schema:bookEdition"3rd ed."
schema:description"The new edition of this textbook continues to provide the most comprehensive overview of the concepts, methods, and research advances in the field; particularly the application of molecular genomics and of neuroimaging. It has been revised and enhanced to capitalize on the strengths of the first and second editions while keeping it up-to-date with the field of psychiatry and epidemiology. This comprehensive publication now includes chapters on experimental epidemiology, gene-environment interactions, the use of case registries, eating disorders, suicide, childhood disorders and immigrant populations, and the epidemiology of a number of childhood disorders. As in the first and second editions, the objective is to provide a comprehensive, easy to understand overview of research methods for the non-specialist."@en
schema:name"Textbook of psychiatric epidemiology"@en

Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.